Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-092861
Filing Date
2024-10-31
Accepted
2024-10-31 16:00:31
Documents
62
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0217646-10q_inmune.htm   iXBRL 10-Q 603547
2 CERTIFICATION ea021764601ex31-1_inmune.htm EX-31.1 11130
3 CERTIFICATION ea021764601ex31-2_inmune.htm EX-31.2 11015
4 CERTIFICATION ea021764601ex32-1_inmune.htm EX-32.1 4674
5 CERTIFICATION ea021764601ex32-2_inmune.htm EX-32.2 4648
  Complete submission text file 0001213900-24-092861.txt   4057785

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20240930.xsd EX-101.SCH 35715
7 XBRL CALCULATION FILE inmb-20240930_cal.xml EX-101.CAL 29972
8 XBRL DEFINITION FILE inmb-20240930_def.xml EX-101.DEF 185543
9 XBRL LABEL FILE inmb-20240930_lab.xml EX-101.LAB 355099
10 XBRL PRESENTATION FILE inmb-20240930_pre.xml EX-101.PRE 193814
64 EXTRACTED XBRL INSTANCE DOCUMENT ea0217646-10q_inmune_htm.xml XML 374937
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 241415111
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)